Related Experiment Video
Updated: May 2, 2026
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
19.8K
Genomic profiling in triple-negative breast cancer
Cornelia Liedtke1, Christof Bernemann2, Ludwig Kiesel2
1Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein/Campus Lübeck, Germany.
Breast Care (Basel, Switzerland)
|February 20, 2014
Summary
Triple-negative breast cancer (TNBC) presents a poor prognosis due to its aggressive nature. This review explores TNBC
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) lacks hormone receptors and HER2/neu expression.
- TNBC patients exhibit a significantly worse prognosis than other breast cancer subtypes.
- TNBC is a heterogeneous disease with diverse clinical and molecular characteristics.
Purpose of the Study:
- To review current data on triple-negative breast cancer.
- To focus on TNBC's mutational and gene expression profiles.
- To examine the association between TNBC and breast cancer stem cells.
Main Methods:
- Literature review of TNBC research.
- Analysis of mutational and gene expression profiling data.
- Examination of studies on breast cancer stem cells in TNBC.
Main Results:
- TNBC is molecularly diverse, impacting treatment strategies.
- Gene expression profiling reveals subtypes within TNBC.
- Breast cancer stem cells are implicated in TNBC progression and recurrence.
Conclusions:
- Understanding TNBC heterogeneity is crucial for developing targeted therapies.
- Further research into TNBC's molecular landscape and stem cell interactions is warranted.
- Identifying therapeutic vulnerabilities in TNBC remains a critical challenge.
